Effect of HIV-1 infection on malaria treatment outcome in Ugandan patients

scientific article published in June 2007

Effect of HIV-1 infection on malaria treatment outcome in Ugandan patients is …
instance of (P31):
scholarly articleQ13442814

External links are
P932PMC publication ID1925269
P698PubMed publication ID17594285
P5875ResearchGate publication ID6243770

P50authorMoses R KamyaQ60043817
Pauline Byakika-KibwikaQ89742292
P2093author name stringEdward Ddumba
P2860cites workEffect of HIV-1 and increasing immunosuppression on malaria parasitaemia and clinical episodes in adults in rural Uganda: a cohort studyQ28139876
Age-dependent acquired protection against Plasmodium falciparum in people having two years exposure to hyperendemic malariaQ33356958
Plasmodium falciparum clinical malaria: lessons from longitudinal studies in SenegalQ33852160
Malaria: drug use and the immune responseQ35224460
Absence of association between Plasmodium falciparum malaria and human immunodeficiency virus infection in children in Kinshasa, ZaireQ36799449
Impact of trimethoprim-sulfamethoxazole prophylaxis on falciparum malaria infection and diseaseQ37339874
Effect of HIV-1 infection on antimalarial treatment outcomes in Uganda: a population-based studyQ38880071
Cotrimoxazole prophylaxis by HIV-infected persons in Uganda reduces morbidity and mortality among HIV-uninfected family membersQ38880788
HIV, malaria parasites, and acute febrile episodes in Ugandan adults: a case-control study.Q38884784
HIV infection may adversely affect clinical response to chloroquine therapy for uncomplicated malaria in childrenQ38885129
Increasing rates of malarial fever with deteriorating immune status in HIV-1-infected Ugandan adults.Q38885142
Predictors of chloroquine treatment failure in children and adults with falciparum malaria in Kampala, UgandaQ38885315
Is there an interaction between human immunodeficiency virus and Plasmodium falciparum?Q38938269
Plasmodium Falciparum malaria and perinatally acquired human immunodeficiency virus type 1 infection in Kinshasa, Zaire. A prospective, longitudinal cohort study of 587 childrenQ39032318
Selected P. falciparum specific immune responses are maintained in AIDS adults in Burkina FasoQ39250463
Severe falciparum malaria and the acquired immunodeficiency syndrome (AIDS) in ZambiaQ39465270
HIV-1 immune suppression and antimalarial treatment outcome in Zambian adults with uncomplicated malariaQ39550259
Epidemiology of drug resistance in malariaQ39587600
Delayed clearance of Plasmodium falciparum in patients with human immunodeficiency virus co-infection treated with artemisinin.Q40557036
Incidence of malaria and efficacy of oral quinine in patients recently infected with human immunodeficiency virus in Kinshasa, ZaireQ40758958
Increased carriage of trimethoprim/sulfamethoxazole-resistant Streptococcus pneumoniae in Malawian children after treatment for malaria with sulfadoxine/pyrimethamineQ41921885
Plasmodium falciparum cross-resistance between trimethoprim and pyrimethamineQ43758891
HIV increases the risk of malaria in women of all gravidities in Kisumu, KenyaQ44394085
Longitudinal cohort study of the epidemiology of malaria infections in an area of intense malaria transmission II. Descriptive epidemiology of malaria infection and disease among childrenQ46227335
Plasmodium falciparum cross resistanceQ46596732
Natural history of Plasmodium falciparum malaria and determining factors of the acquisition of antimalaria immunity in two endemic areas, Dielmo and Ndiop (Senegal).Q47881878
Malaria, 1982-1997Q72991618
P433issue2
P921main subjectUgandaQ1036
malariaQ12156
P304page(s)86-92
P577publication date2007-06-01
P1433published inAfrican Health SciencesQ4689779
P1476titleEffect of HIV-1 infection on malaria treatment outcome in Ugandan patients
P478volume7

Reverse relations

cites work (P2860)
Q34137766Artemisinin-based combination therapies are efficacious and safe for treatment of uncomplicated malaria in HIV-infected Ugandan children
Q93740132Editorial
Q33650105Guidelines for the Prevention and Treatment of Opportunistic Infections among HIV-exposed and HIV-infected children: recommendations from CDC, the National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of Amer
Q34764823Low prevalence of Plasmodium falciparum antigenaemia among asymptomatic HAART-treated adults in an urban cohort in Uganda
Q36901948Malaria and HIV among pediatric inpatients in two Tanzanian referral hospitals: A prospective study
Q33733033Outcome of artemether-lumefantrine treatment for uncomplicated malaria in HIV-infected adult patients on anti-retroviral therapy
Q21133667Safety and efficacy of co-trimoxazole for treatment and prevention of Plasmodium falciparum malaria: a systematic review
Q33635019Update on the efficacy, effectiveness and safety of artemether-lumefantrine combination therapy for treatment of uncomplicated malaria.

Search more.